Educators weigh how to use AI without losing critical thinking

• by Julia Cipriano, MS, CMPP

• September 10, 2026

Extended antiviral therapy may not improve long COVID

Nirmatrelvir–ritonavir for up to 25 days failed to improve cognitive, autonomic, or exercise symptoms compared with placebo in a phase 2 trial.

• by Andrea Surnit

• September 4, 2026

• 4 min

Seminal fibrils may facilitate mpox infection

Seminal fluid increased mpox virus infection across primary cells and viral isolates, with semen-derived amyloid fibrils promoting viral attachment and uptake.

• by Andrea Surnit

• September 9, 2026

• 4 min

FDA approves oral dermatomyositis therapy

Phase 3 findings show improvements in physical function and skin disease activity.

• by Kathryn Wighton

• August 28, 2026

• 2 min